Wehler, TC; Graf, C; Biesterfeld, S et al.
Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced DiseaseJ Oncol. 2008 S. 10.1155/626340
Gillissen, A; Buhl, R; Kardos, P et al.
Studienendpunkte bei der chronisch-obstruktiven Lungenerkrankung (COPD): "Minimal Clinically Important Difference".Pneumologie. Bd. 62. H. 3. 2008 S. 149-55
Miesbach, W; Zapletal, C; Asmelash, G et al.
Successful liver transplantation in two patients with severe haemophilia AI. Scharrer, W. Schramm (Hrsg). 37. Hemophilia Symposium Hamburg 2007. Berlin Heidelberg: Springer-Verlag 2008
Hess, G; Meyer, RG; Schuch, B et al.
Sustained remissions and low rate of BCR-ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: a 5-year follow up.Am J Hematol. Bd. 83. H. 3. 2008 S. 178-84
Theobald, M; Voss, RH
T-Zell-Rezeptor-TransferHuber C, Rammensee H-G, Wölfel T, Britten CM (Hrsg). Krebsimmuntherapien. Deutscher Ärzte-Verlag 2008
Hahnel, PS; Thaler, S; Antunes, E et al.
Targeting AKT signaling sensitizes cancer to cellular immunotherapy.Cancer Res. Bd. 68. H. 10. 2008 S. 3899-906
Stolz, C; Hess, G; Hahnel, PS et al.
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis.Blood. Bd. 112. H. 8. 2008 S. 3312-21
Britten, CM; Gouttefangeas, C; Welters, MJ et al.
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.Cancer Immunol Immunother. Bd. 57. H. 3. 2008 S. 289-302
von Haussen, J; Koczulla, R; Shaykhiev, R et al.
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.Lung Cancer. Bd. 59. H. 1. 2008 S. 12-23
Kasper, S; Breitenbuecher, F; Hoehn, Y et al.
The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia.Leuk Res. Bd. 32. H. 11. 2008 S. 1698-708